Pharmagen Inc. (OTCMKTS:PHRX) Sees Large Increase in Short Interest

Pharmagen Inc. (OTCMKTS:PHRX) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 7,400 shares. Based on an average trading volume of 1,000 shares, the short-interest ratio is presently 7.4 days.

Pharmagen Price Performance

Pharmagen has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.

Pharmagen Company Profile

Pharmagen, Inc distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes.